Cervical Cancer Study

Cervical cancer has become a preventable disease with effective vaccination & screening programs.

Cervical Cancer Study
Table of Contents

 About the study findings:

  • India reported 1,23,907 new cases of cervical cancer and 77,348 deaths, according to the study.

 

Countries-wise findings of Cervical Cancer:

  • Though the incidence of cervical cancer has decreased in many parts of the world —notably in Latin America, Asia, Western Europe, and North America — over the past three decades, the burden remains high in many low- and middle-income countries.
  • The study found major declines in cases in Latin American countries including Brazil, Colombia, and Costa Rica; Asian nations like India, Thailand, and South Korea; and Poland, Slovenia, and the Czech Republic in Eastern Europe.
  • Countries with the largest average declines in incidence rates per year include Brazil (8%), Slovenia (7%), Kuwait (7%), and Chile (6%).
  • The highest increases in rates were seen in Latvia (4%), Japan (3%), Ireland (3%), Sweden (3%), Norway (2%), Northern Ireland (2%), Estonia (2%), and China (2%).

 

Database:

  • The study used the International Agency for Research on Cancer’s (IARC) Global Cancer Observatory (GLOBOCAN) 2020 database to estimate the burden of cervical cancer incidence and mortality rates in 185 countries.

 

Incidence:

  • In 2020, overall incidence was 13 per 1,00,000 women; mortality was 7 per 1,00,000 women.
  • As many as 172 out of the 185 countries saw more than the 4 cases per 1,00,000 women per year threshold for elimination set by the World Health Organisation (WHO).
  • The development of effective vaccination against the human papilloma virus (HPV), which causes cervical cancer, and screening programmes have made cervical cancer a largely preventable disease.

 

Target:

  • In 2020, the WHO announced a target to accelerate the elimination of the disease as a public health problem, aiming to reduce incidence to less than 4 cases per 1,00,000 women per year in every country by 2030.

 


Q1) What is Human papillomavirus Infection?

Human papillomavirus (HPV) is a viral infection that is  passed between people through skin-to-skin contact. There are over 100 varieties of HPV, more than 40 of which are passed through sexual contact and can affect your genitals, mouth, or throat.

Source: Indian Express

Update Icon
Latest UPSC Exam 2026 Updates

Date IconLast updated on August, 2026

UPSC Mains 2026 commenced on 21st August 2026 and will continue through 30th August 2026, as per the official examination schedule.

UPSC Mains Question Paper 2026 is out now for Essay & GS Paper 1, 2, 3 & 4.

UPSC Mains GS Paper 1 2026 is out now.

UPSC Mains GS Paper 2 2026 is out now.

UPSC Mains GS Paper 3 2026 is out now.

UPSC Mains GS Paper 4 2026 is out now.

→ Check out the latest UPSC Syllabus 2026 here.

UPSC Mains Admit Card 2026 is now out.

→ Enroll in Vajiram & Ravi’s UPSC Mains Test Series 2027 for structured answer writing practice, expert evaluation, and exam-oriented feedback.

→ Join Vajiram & Ravi’s UPSC Mentorship Program 2027 for personalized guidance, strategy planning, and one-to-one support from experienced mentors.

→ Go through the UPSC Mains Previous Year Papers to enhance your preparation.

→ Download UPSC Mains Essay Paper 2025, UPSC Mains GS Paper-I 2025, UPSC Mains GS Paper-II 2025, UPSC Mains GS Paper-III 2025, UPSC Mains GS Paper-IV 2025, UPSC Mains English (Compulsory) Paper 2025, UPSC Mains Hindi (Qualifying) Paper 2025 here.

→ UPSC has released UPSC Toppers List 2025 with the Civil Services final result on its official website.

UPSC Calendar 2027 has been released.

→ Also check Best UPSC Coaching in India

UPSC GS Course 2027
UPSC GS Course 2027
₹1,80,000
Enroll Now
GS Foundation Course 2 Yrs
GS Foundation Course 2 Yrs
₹2,45,000
Enroll Now
UPSC Mentorship Program
UPSC Mentorship Program
₹69000
Enroll Now
UPSC Sureshot Mains Test Series
UPSC Sureshot Mains Test Series
₹27000
Enroll Now
Prelims Powerup Test Series
Prelims Powerup Test Series
₹14000
Enroll Now
Enquire Now